查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1820079

2025-2033年經皮給藥系統市場技術、應用與地區報告

Transdermal Drug Delivery Systems Market Report by Technology, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球透皮給藥系統市場規模達71億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到115億美元，2025-2033年期間的複合年成長率（CAGR）為5.22%。推動市場發展的因素多種多樣，包括糖尿病、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升、老年人口不斷成長以及法規核准的不斷增加。

透皮給藥系統市場趨勢：

慢性病盛行率不斷上升

由於久坐不動的生活方式和不良的飲食習慣，人們越來越容易患上糖尿病、心臟病、類風濕性關節炎、高血壓和神經系統疾病等慢性疾病。患有這些疾病的患者需要長期持續服藥，促使他們尋求可靠且便捷的給藥方式。透皮貼片是最佳選擇，因為它可以持續穩定地輸送藥物，無需頻繁使用。對能夠提高患者依從性的非侵入性且易於使用的替代療法的需求日益成長，這推動了透皮給藥系統市場的成長。使用經皮給藥系統的患者只需定期貼上貼劑，這有助於降低漏服的可能性。慢性病患者正在尋找更方便的解決方案。根據世界神經病學聯合會的數據，一項開創性的全球疾病負擔 (GBD) 研究表明，到 2050 年，腦部疾病患者人數預計將翻倍。

老年人口不斷增加

隨著老齡化人口對透皮給藥系統的需求日益成長，市場規模也不斷擴大。隨著年齡的成長，人們常常會患上多種慢性疾病，包括神經系統疾病、糖尿病、類風濕性關節炎和心血管疾病。老年人可能難以長期堅持服用這些藥物。老年人無法吞嚥藥物是另一個典型問題。經皮給藥系統提供了一種便捷的替代方案，因為它可以避免口服藥物，並提供一種非侵入性持續釋放藥物的方法。此外，老年人對更簡單的解決方案的需求日益成長，以減輕每日多次服藥的負擔，這為透皮給藥系統市場帶來了良好的前景。世界衛生組織 (WHO) 稱，到 2050 年，80 歲及以上老年人口預計將達到 4.26 億。

監管批准不斷增加

中國國家藥品監督管理局 (NMPA) 於2023年10月31日批准綠葉製藥集團的新型藥物利斯的明每週兩次透皮貼劑，用於治療輕度至中度阿茲海默症 (AD)。監管機構正在擴大批准更廣泛的透皮貼片產品。這涵蓋了用於荷爾蒙替代、疼痛緩解甚至免疫接種等一系列藥物的貼片。透皮貼片系統正變得越來越普及和多樣化，吸引了越來越多的患者和醫療保健專業人員。

透皮給藥系統市場細分：

按技術分類：

  • 電穿孔
  • 射頻
  • 離子電滲透療法
  • 微孔化
  • 熱的
  • 機械陣列
  • 超音波
  • 其他

離子電滲透療法佔大部分市場佔有率

離子電滲透療法利用微弱電流促進藥物經皮擴散。它因其能夠精準輸送藥物劑量並降低副作用而備受青睞。它特別適用於疼痛管理、局部治療和全身給藥，使其成為透皮市場的首選。它是一種非侵入性療法，對於希望避免注射或口服藥物的患者來說，尤其是在需要長期或頻繁給藥的情況下，是一種更理想的選擇。

按應用分類：

  • 中樞神經系統
  • 疼痛管理
  • 心血管
  • 荷爾蒙
  • 其他

疼痛管理佔產業最大佔有率

個人對疼痛管理的日益關注推動了市場的成長。透皮貼片系統能夠持續且可控制地釋放止痛藥物，對慢性疼痛患者非常有益。這避免了頻繁服藥的需要，為患者帶來了更大的便利。透皮貼片是口服藥物和注射劑的非侵入性替代方案。用於疼痛管理的透皮給藥系統透過持續低劑量給藥，提供了一種減少鴉片類藥物用量的替代方案，既能有效控制疼痛，又能降低藥物濫用的可能性。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大的透皮給藥系統市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是透皮給藥系統最大的區域市場。

北美擁有完善的醫療保健體系，並擁有尖端的醫療技術。由於支持其使用和分銷的基礎設施完善，該地區的患者和醫療保健提供者更有可能採用先進的藥物輸送系統。北美，尤其是美國，慢性病發生率高，需要對患者進行長期持續的藥物管理。此外，該地區老年人口的不斷成長也推動了市場的成長。根據城市研究所 (Urban Institute) 報告，預計到 2040 年，65 歲及以上的美國人數量將達到 8,000 萬人。

（請注意，這只是關鍵參與者的部分名單，完整名單將在報告中提供。）

  • 頂尖企業正專注於開發適用於各種治療領域的新型透皮系統。一些公司也在開發能夠輸送更大分子（包括生物製劑）的貼片。此外，一些關鍵企業正在將透皮系統的應用擴展到精神健康治療領域。許多公司正在與研究機構、生技公司和其他製藥公司建立合作關係，共同開發或授權新的透皮技術。他們還獲得了資金和產品核准，這正在增強市場成長。 2023年9月26日，Satio獲得了美國國立衛生研究院、美國衛生與公眾服務部高級研究計畫署（ARPA-H）350萬美元的資助，用於開發一種新型家用遠端可控透皮給藥裝置SatioRx(TM)。

本報告回答的關鍵問題：

  • 全球透皮給藥系統市場迄今表現如何，未來幾年將如何表現？
  • 全球市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的市場？
  • 基於技術的市場區隔是怎樣的？
  • 市場上最有吸引力的技術是什麼？
  • 根據應用，市場是如何分類的？
  • 市場上最有吸引力的應用程式是什麼？
  • 市場的競爭結構是怎麼樣的？
  • 全球透皮給藥系統市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 全球透皮給藥系統市場迄今表現如何，未來幾年將如何表現？
  • 全球市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的市場？
  • 基於技術的市場區隔是怎樣的？
  • 市場上最有吸引力的技術是什麼？
  • 根據應用，市場是如何分類的？
  • 市場上最有吸引力的應用程式是什麼？
  • 市場的競爭結構是怎麼樣的？
  • 全球透皮給藥系統市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球透皮給藥系統市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依技術

  • 電穿孔
  • 射頻
  • 離子電滲透療法
  • 微孔化
  • 熱的
  • 機械陣列
  • 超音波
  • 其他

第7章：市場區隔：依應用

  • 中樞神經系統
  • 疼痛管理
  • 心血管
  • 荷爾蒙
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Acrux Limited
    • Boehringer Ingelheim International GmbH
    • Hisamitsu Pharmaceutical Co. Inc.
    • Lavipharm SA
    • LEAD CHEMICAL Co. Ltd.
    • Luye Pharma Group
    • Nutriband Inc.
    • Viatris Inc.
Product Code: SR112025A3983

The global transdermal drug delivery systems market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. There are various factors that are driving the market, which include the growing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and neurological disorders, rising geriatric population, and increasing regulatory approvals.

Transdermal Drug Delivery Systems Market Trends:

Growing Prevalence of Chronic Diseases

People are becoming prone to chronic illnesses like diabetes, heart disease, rheumatoid arthritis, hypertension, and neurological disorders because of sedentary lifestyles and poor eating habits. Patients with these disorders need to take medication continuously for a longer time, which prompts them to look for reliable and convenient drug delivery options. For this, transdermal patches work best as they provide a steady flow of medication throughout time without requiring frequent use. The rising demand for non-invasive and easy-to-use alternative that can enhance patient compliance is impelling the transdermal drug delivery systems market growth. Patients using transdermal systems just need to apply a patch on a regular basis, which helps to lower the possibility of missing doses. People with chronic diseases are looking for solutions that offer enhanced convenience. According to the World Federation of Neurology, a groundbreaking new Global Burden of Disease (GBD) study shows that the number of people living with brain disease is expected to double by 2050.

Increasing Geriatric Population

The market is expanding as a result of the growing need for transdermal medication delivery systems among the aging population. People frequently acquire several chronic illnesses as they get older, including neurological disorders, diabetes, rheumatoid arthritis, and cardiovascular ailments. It might be difficult for elderly individuals to take these medications consistently over an extended period. The inability of the elderly to swallow medications is another typical problem. Transdermal drug delivery systems offer a convenient alternative because of their ability to bypass the need to take oral medications and provide a non-invasive method for sustained drug release. Furthermore, the growing need for simpler solutions among older individuals that lowers the burden of multiple daily doses is offering a favorable transdermal drug delivery systems market outlook. The World Health Organization (WHO) claims that the number of people aged 80 years or older is expected to reach 426 million by 2050.

Rising Regulatory Approvals

The National Medical Products Administration (NMPA) of China approved Luye Pharma Group's novel medicine, Rivastigmine Twice Weekly Transdermal Patch, on October 31, 2023, for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). Regulatory agencies are increasingly approving a broader range of transdermal products. This covers patches for a range of medicinal applications such as hormone replacement, pain relief, and even immunizations. Transdermal systems are becoming more widely available and varied, which is drawing in more patients and healthcare professionals.

Transdermal Drug Delivery Systems Market Segmentation:

Breakup by Technology:

  • Electroporation
  • Radiofrequency
  • Iontophoresis
  • Microporation
  • Thermal
  • Mechanical Arrays
  • Ultrasound
  • Others

Iontophoresis accounts for the majority of the market share

Iontophoresis uses a small electric current to improve the diffusion of drugs via the skin. It is favored because of its ability to deliver precise dosages of medication while lowering side effects. It is especially useful for pain management, localized treatment, and systemic drug delivery, making it a leading choice in the transdermal market. It is non-invasive approach, which makes it a preferable alternative for patients who wish to avoid injections or oral medications, especially when long-term or frequent drug administration is required.

Breakup by Application:

  • Central Nervous System
  • Pain Management
  • Cardiovascular
  • Hormone
  • Others

Pain management holds the largest share of the industry

The rising focus on pain management among individuals is contributing to the market growth. Transdermal systems provide continuous and controlled release of pain-relieving medications, which is highly beneficial for chronic pain sufferers. This avoids the need for frequent dosing, making it more convenient for patients. Transdermal patches are a non-invasive alternative to oral medications and injections. Transdermal drug delivery systems for pain management provide an opioid-sparing alternative by delivering low and sustained doses that can manage pain effectively while reducing abuse potential.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest transdermal drug delivery systems market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for transdermal drug delivery systems.

North America has a well-established healthcare system with access to cutting-edge medical technologies. Patients and healthcare providers in the region are more likely to adopt advanced drug delivery systems owing to the availability of infrastructure that supports their use and distribution. North America, particularly the United States, faces high prevalence of chronic diseases, requiring long-term and consistent medication management among individuals. Apart from this, the rising geriatric population in the region is bolstering the market growth. The number of Americans aged 65 and older is predicted to reach 80 million in 2040, as reported by the Urban Institute.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the transdermal drug delivery systems industry include 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • Top players are focusing on developing new transdermal systems for various therapeutic areas. Companies are also developing patches that deliver larger molecules including biologics. Moreover, key players are expanding the use of transdermal systems into mental health treatments. Many companies are entering into partnerships with research institutions, biotechnology firms, and other pharmaceutical companies to co-develop or license new transdermal technologies. They are also receiving funding and product approvals, which is strengthening the market growth. On 26 September 2023, Satio received funding of US$ 3.5 million by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services to develop SatioRx(TM) a novel at-home, remotely controllable transdermal drug delivery device.

Key Questions Answered in This Report:

  • How has the global transdermal drug delivery systems market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global transdermal drug delivery systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Drug Delivery Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Electroporation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radiofrequency
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Iontophoresis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microporation
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Thermal
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Mechanical Arrays
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ultrasound
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Central Nervous System
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormone
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Acrux Limited
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Boehringer Ingelheim International GmbH
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Hisamitsu Pharmaceutical Co. Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Lavipharm S.A.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 LEAD CHEMICAL Co. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Luye Pharma Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nutriband Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Viatris Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials

List of Figures

  • Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
  • Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
  • Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
  • Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players